Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jessica J Manson

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
The Lancet. Rheumatology|August 23, 2021
Haemophagocytic lymphohistiocytosis secondary to COVID-19: a case seriesLuke Flower, Nick Laundy, Maryam Khosravi, et al.
Arthritis Research & Therapy|October 16, 2009
Relationship between anti-dsDNA, anti-nucleosome and anti-alpha-actinin antibodies and markers of renal disease in patients with lupus nephritis: a prospective longitudinal studyJessica J Manson, Alexander Ma, Pauline Rogers, et al.
The Lancet. Rheumatology|December 1, 2025
Trends in mortality due to haemophagocytic lymphohistiocytosis across 29 European countries from 2011 to 2021: a retrospective, international, population-based studyLeher Gumber, Reza Omidvar, Francesca Gonnelli, et al.
Journal of Internal Medicine|December 7, 2021
Incidence and survival of haemophagocytic lymphohistiocytosis: A population-based cohort study from EnglandJoe West, Tim R Card, Mark J Bishton, et al.
ACR Open Rheumatology|November 29, 2019
Characterization of a Subset of Patients With Rheumatoid Arthritis for Whom Current Management Strategies are InadequateClaire M Bradford, Thomas McDonnell, Divya Raj, et al.
Frontiers in Immunology|December 21, 2018
Low Percentage of Signal Regulatory Protein α/β<sup>+</sup> Memory B Cells in Blood Predicts Development of Anti-drug Antibodies (ADA) in Adalimumab-Treated Rheumatoid Arthritis PatientsLaura Magill, Marsilio Adriani, Véronique Berthou, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|October 15, 2025
Simple hyperinflammation scores predict mortality in hospitalized patients with COVID-19 and offer a personalized medicine approach to dexamethasone interventionAlexandra E Oppong, Leda Coelewij, Matthew Hutchinson, et al.
Cell Metabolism|March 28, 2020
Microbiota-Derived Metabolites Suppress Arthritis by Amplifying Aryl-Hydrocarbon Receptor Activation in Regulatory B CellsElizabeth C Rosser, Christopher J M Piper, Diana E Matei, et al.
Med (New York, N.Y.)|July 23, 2021
Intestinal barrier dysfunction plays an integral role in arthritis pathology and can be targeted to ameliorate diseaseDiana E Matei, Madhvi Menon, Dagmar G Alber, et al.
The Lancet. Rheumatology|May 27, 2026
Baricitinib and ruxolitinib use through the UK HLH NetworkAmelia Holloway, Dreen Gul, Alexandra E Oppong, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
The Lancet. Rheumatology|August 23, 2021
Haemophagocytic lymphohistiocytosis secondary to COVID-19: a case seriesLuke Flower, Nick Laundy, Maryam Khosravi, et al.
Arthritis Research & Therapy|October 16, 2009
Relationship between anti-dsDNA, anti-nucleosome and anti-alpha-actinin antibodies and markers of renal disease in patients with lupus nephritis: a prospective longitudinal studyJessica J Manson, Alexander Ma, Pauline Rogers, et al.
The Lancet. Rheumatology|December 1, 2025
Trends in mortality due to haemophagocytic lymphohistiocytosis across 29 European countries from 2011 to 2021: a retrospective, international, population-based studyLeher Gumber, Reza Omidvar, Francesca Gonnelli, et al.
Journal of Internal Medicine|December 7, 2021
Incidence and survival of haemophagocytic lymphohistiocytosis: A population-based cohort study from EnglandJoe West, Tim R Card, Mark J Bishton, et al.
ACR Open Rheumatology|November 29, 2019
Characterization of a Subset of Patients With Rheumatoid Arthritis for Whom Current Management Strategies are InadequateClaire M Bradford, Thomas McDonnell, Divya Raj, et al.
Frontiers in Immunology|December 21, 2018
Low Percentage of Signal Regulatory Protein α/β<sup>+</sup> Memory B Cells in Blood Predicts Development of Anti-drug Antibodies (ADA) in Adalimumab-Treated Rheumatoid Arthritis PatientsLaura Magill, Marsilio Adriani, Véronique Berthou, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|October 15, 2025
Simple hyperinflammation scores predict mortality in hospitalized patients with COVID-19 and offer a personalized medicine approach to dexamethasone interventionAlexandra E Oppong, Leda Coelewij, Matthew Hutchinson, et al.
Cell Metabolism|March 28, 2020
Microbiota-Derived Metabolites Suppress Arthritis by Amplifying Aryl-Hydrocarbon Receptor Activation in Regulatory B CellsElizabeth C Rosser, Christopher J M Piper, Diana E Matei, et al.
Med (New York, N.Y.)|July 23, 2021
Intestinal barrier dysfunction plays an integral role in arthritis pathology and can be targeted to ameliorate diseaseDiana E Matei, Madhvi Menon, Dagmar G Alber, et al.
The Lancet. Rheumatology|May 27, 2026
Baricitinib and ruxolitinib use through the UK HLH NetworkAmelia Holloway, Dreen Gul, Alexandra E Oppong, et al.
Pageof 5